ArticleJournal of translational medicine2024

AC099850.3 promotes HBV-HCC cell proliferation and invasion through regulating CD276: a novel strategy for sorafenib and immune checkpoint combination therapy.

Aoxiao He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.